Needs Assessment of Hepatitis C Testing, Treatment and Support Services: Survey of Laboratories in Scotland Undertaking Hepatitis C Testing.

Slides:



Advertisements
Similar presentations
Consolidated User Story 1: Chronic Diseases (cancer, occupational health) Chronic Diseases, Outpatient Flow Patient, Provider/Physician, Laboratory, PH.
Advertisements

Summary of SCR recommendations relevant to NHS
Establishing a Managed Care Network for Hepatitis C
Quality Education for a Healthier Scotland Psychology Psychosocial Interventions - Paediatric Psychology Children and Young People’s Health support Group.
Observing and exploring the implications of alcohol-related acute hospital data trends in NHS Ayrshire & Arran Dr. Regina McDevitt Dr. Alister Hooke Dr.
Dr John Dillon NHS Tayside Brian Stephens NHS Tayside Jan Tait NHS Tayside Daniel Kelly CAIR Scotland Ingrid Hainey CAIR Scotland Mike Burns CAIR Scotland.
Improved Reflexive Testing Algorithm for Hepatitis C Infection Using Signal-to-Cutoff Ratios of a Hepatitis C Virus Antibody Assay K.K.Y. Lai, M. Jin,
Teledermatology in Scotland Update C. Morton, Stirling, Scotland.
Hepatitis C Action Plan Prevention Working Group Findings and recommendations Norah Palmateer Health Protection Scotland Greater Glasgow & Clyde MCN June.
Exploring the Psychology Workforce Liz Jamieson Information&Statistics Division NHS Education Scotland.
Alistair Armour Inspector Custody Division Healthcare/Forensic Medical Services Project Johnstone Police Office T/N: External Introduction.
HCV Testing trends. General remarks on HCV testing Trends in HCV testing in NI – An 11 year dataset RAGS- blood lab initiative
Student Fitness to Practise
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction.
Hyperglycaemia and diabetes risk among 100,000 patients Opportunities and challenges in using routine healthcare data Dr David McAllister Clinical Lecturer.
Clinical Forum: Women in Forensic Mental Health Settings
SDF Conference THE NEW GMS ENHANCED CONTRACT Professor Richard Simpson Specialist in Addiction September 30 th 2004.
Facts about the Trust £110 million pound turnover 1,619 staff plus staff employed by contractors 33,365 inpatient and day cases were treated 10,670 elective.
SHINE Study Day 4 April 2003 CLA Survey - NHS in Scotland 2002 Christine Blake Manager – Survey Operations.
Delivering 18 Weeks Referral to Treatment Standard - Improving the Management of Diagnostic Services Jim Crombie Chair 18 Weeks Diagnostics Task and Finish.
An Outbreak of Legionnaires’ Disease in NHS Greater Glasgow and Clyde and NHS Lanarkshire 2011 Dr Sonya Scott StR Public Health NHS GGC
UNDERTAKING FLYING START NHS TM : CHOICES AND CHALLENGES FOR NEWLY QUALIFIED PRACTITIONERS Authors: Michelle Roxburgh 1, Pauline Banks 2 and Helen Kane.
Developing a 5 year Sexual Health Plan for Hertfordshire PH & Localism Cabinet Panel Louise Smith Deputy Director, Public Health 23.
Heart Failure: a community-based diagnostic clinic & service
Needs Assessment of Hepatitis C Testing, Treatment and Support Services: Survey of General Practitioners in Primary Care.
Alzheimer Scotland Dementia Post Diagnostic Support Service Edinburgh January 2014.
HER2 Human Epidermal growth factor Receptor 2 Excess HER2 gene leads to over expression of HER2 protein 20-30% Of breast cancers over express HER2.
TREATMENT TIME GUARANTEE M Brown May Aims of the session TTG and its Waiting Times context Measurement –Reasonable offer –Impact of Board decisions.
Paul Klapper Clinical Virology Manchester Royal Infirmary hepatitis C dried blood spot testing.
Joan Blackwood Clinical Lead MH Service Re-design Frances Paton Business Intelligence Manager (Partnerships) Fiona McMahon Senior Practitioner, Re-admissions/Service.
Implementing Haemoglobinopathy Screening in Scotland Summary of screening, laboratory and clinical service mapping exercise May 2009.
Acknowledgements Natalie Weir, for help with the charts. Conclusion Toxicities were broadly as expected and interestingly, most care issues were associated.
Research Study Gavin Bryce Health Promotion Specialist NHS Brighton and Hove Provider-initiated HIV testing in primary care.
A Universal Testing Programme for Blood Borne Viruses in an Urban Emergency Department – a call for widespread ED testing in Ireland S O’Connell 1, D Lillis.
Molecular Monitoring in CML the process and questions we can answer Letizia Foroni.
Hepatitis C Needs Assessment: Contributions from the National HCV Diagnosis and Local Clinical Databases.
RECAP What is primary healthcare?
Scottish Care Nurses Forum. 14 Territorial Boards NHS Ayrshire and Arran NHS Borders NHS Dumfries and Galloway NHS Western Isles NHS Fife NHS Forth.
Action for Sick Children Scotland Family Facilities and Access Survey 2012/13.
Data and Audit Working Group Ciara McColgan Consultant Paediatrician Greater Glasgow and Clyde.
Marked increase in first-time HIV diagnoses in Ontario, 2002.
Moffat Programme NHS Carer Information Strategies Learning and Sharing Event 3rd February 2010.
NPS and Importance of Information Sharing Dr Richard Stevenson A&E Department, Glasgow Royal Infirmary Dr Hazel Torrance Forensic Medicine and Science.
South West Hepatitis C Needs Assessment Dr Maya Gobin Health Protection Services (South West)
Services and C Leon Wylie Lead Officer Hepatitis Scotland.
Alan Bigham Programme Manager (Volunteering) Scottish Health Council Feedback on the needs analysis survey.
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction
Cascade of care for persons newly diagnosed
R. Cavallo  Clinical Microbiology and Infection 
Capital Investment Network Scottish Government Update
The Role of the Oral Dental Specialty Group
Purpose of Presentation
Purpose of Presentation
Grampian COPD MCN Delivering Spirometry in a Community Pharmacy setting, a rural solution? Small I (1,2), Clelland J (1,2), Robertson W (1), Freeman D.
Purpose of Presentation
Gary Jenkins Director, Regional Services 27 September 2016
NHS Grampian Annual Review
Virological tools to diagnose and monitor hepatitis C virus infection
Management of Outbreaks of Acute Respiratory Illness in Care Homes Out of Season and In Season Other areas: Where the home feels that their resident needs.
Introduction To Medical Technology
Leading Better Care and Releasing Time to Care
Division of Viral Hepatitis, CDC
Health Protection Surveillance Centre
Lanarkshire Integrated Sexual Health Service
FORENSIC MENTAL HEALTH SERVICES MANAGED CARE NETWORK An introduction
Varicella Vaccine Efficacy Estimates
Hepatitis C Testing, Treatment, Care and Support
Presentation transcript:

Needs Assessment of Hepatitis C Testing, Treatment and Support Services: Survey of Laboratories in Scotland Undertaking Hepatitis C Testing

Survey objectives: i)to describe the existing provision of laboratory Hepatitis C testing services across Scotland ii)to examine the way in which individual laboratories operate with regard to Hepatitis C testing

Survey response rate: Of 25 laboratories surveyed, 24 responses received 92% response rate Survey period: Data provided for period 1 st Jan. to 31 st Dec. 2006

antibody tests antibody tests antibody tests antibody tests antibody tests Hepatitis C antibody tests by NHS Board (where test performed), 2006 Not known (cf. 40,000 in 2002/2003) N=61,700 HCV antibody test

antibody tests antibody tests antibody tests 8000 – antibody tests antibody tests Hepatitis C antibody tests by NHS Board (where test performed), 2006 N=61,700 HCV antibody tests Grampian (13%) Tayside (8%) Lothian (19%) Ayrshire & Arran (8%) Greater Glasgow & Clyde (35%) Not known

antibody tests antibody tests antibody tests 8000 – antibody tests antibody tests Location of 14 Hepatitis C antibody testing laboratories* N=61,700 HCV antibody tests Hepatitis C antibody testing laboratory Hepatitis C testing reference laboratory Not known * 2 reference and 12 local laboratories

Hepatitis C antibody tests in Scotland, 2006 Total HCV antibody tests (from laboratory survey): 61,700 Total HCV antibody positive tests (from laboratory survey): 3,141 New HCV antibody positive diagnoses (from National 1,520 Hepatitis C Diagnoses Database): 2.5% of all HCV antibody tests were new HCV diagnoses

Source of all Hepatitis C antibody tests in Scotland, 2006 Source of test requestAll HCV antibody tests (N=61,700) GP25% Hospital inpatient21% Renal16% Hospital outpatient (not GUM) 15% GUM clinic9% Occupational Health9% Counselling Clinic3% Prison1% Other1% * Data on source of test provided by 2 reference laboratories and 10/12 local laboratories

Source of all Hepatitis C antibody tests in Scotland, 2006 Source of test requestAll HCV antibody tests (N=61,700) New HCV antibody positive tests (N=1,520) GP25% Hospital inpatient21%11% Renal16%0% Hospital outpatient (not GUM) 15%43% GUM clinic9%6% Occupational Health9%3% Counselling Clinic3%9% Prison1%2% Other1% * Data on source of test provided by 2 reference laboratories and 10/12 local laboratories

Source of all Hepatitis C antibody tests in Scotland, 2006 Source of test requestAll HCV antibody tests (N=61,700) New HCV antibody positive tests (N=1,520) New HCV diagnosis rate (per 1,000 tests) GP25% 25 Hospital inpatient21%11%13 Renal16%0%0 Hospital outpatient (not GUM) 15%43%72 GUM clinic9%6%15 Occupational Health9%3%8 Counselling Clinic3%9%73 Prison1%2%48 Other1% 11 Overall100% 25 * Data on source of test provided by 2 reference laboratories and 10/12 local laboratories

Hepatitis C PCR testing: 3 laboratories undertake PCR testing (for diagnostic and monitoring purposes) - a) West of Scotland Specialist Virology Centre (WSSVC) b) East of Scotland Specialist Virology Centre (ESSVC) c) Medical Microbiology Laboratory, Ninewells Hospital In 2006, 5700 PCR tests performed; 70% at WSSVC, 22% at ESSVC, 8% at Ninewells Hospital

Hepatitis C genotyping: 2 specialist virology centres in Glasgow and Edinburgh perform HCV genotyping

Genotype Among persons diagnosed with Hepatitis C during 2004 – 2006 n% of N Total number of tests (N)1550 Hepatitis C genotyping: * Data extracted from National Hepatitis C Diagnoses Database

Negative test result Local laboratories antibody testing 1st sample (n=11) Antibody result reported to source of request (n=11) Local laboratory testing/reporting algorithm following a negative antibody test result 1 st sample

Local laboratories antibody testing 1st sample (n=11) Local laboratory testing algorithms following a positive antibody test result * Responses are not mutually exclusive Positive test result

Local laboratories antibody testing 1st sample (n=11) Local laboratory testing algorithms on second samples 2 nd sample Positive test result 1 st sample * Responses are not mutually exclusive Second sample requested (n=7)

Antibody result reported to source of request (n=11) Negative test result Local laboratories antibody testing 1st sample (n=11) Confirmed antibody and PCR results reported to source of request (n=8) PCR result reported to source of request (n=2) PCR result only reported to source of request (n=2) Antibody and PCR results reported to source of request (n=1) 2 nd sample Local laboratory reporting algorithms Antibody result only reported to source of request (n=6) Positive test result 1 st sample No results reported to source of test request (n=1) No further results reported to source of request (n=4) Second sample requested (n=7)

Reference laboratory testing/reporting algorithms Confirmation PCR testing only at Ref. Lab. (n=1) Second sample requested for confirmation testing (n=2) Negative test result Reference laboratories antibody testing 1st sample (n=2) 1 st sample 2 nd sample Positive test result Initial sample tested for PCR at ref. lab. (n=2) Confirmation antibody and PCR testing at Ref. Lab. (n=1)

Reference laboratory testing/reporting algorithms Confirmation PCR testing only at Ref. Lab. (n=1) Second sample requested for confirmation testing (n=2) Result reported to source of request (n=2) Negative test result Reference laboratories antibody testing 1st sample (n=2) 1 st sample 2 nd sample Antibody result reported to source of request (n=1) Positive test result PCR result reported to source of request (n=1) Initial sample tested for PCR at ref. lab. (n=2) Confirmed antibody and PCR results reported to source of request (n=1) Confirmation antibody and PCR testing at Ref. Lab. (n=1)

Test result turn-around times* i)Hepatitis C antibody test results 12/14 laboratories provided data with median turn-around time of days reported (range 1-3 days to days) * From date of initial sample at laboratory to date of reporting result to test request source

Test result turn-around times ii)Hepatitis C PCR test results 11/14 laboratories provided data with median turn-around time of days reported (range 8-14 days to days) * From date of initial sample at laboratory to date of reporting result to test request source

Summary: At least one Hepatitis C antibody testing laboratory located in 10 of 14 NHS Board areas In Scotland, approx. 50% increase in amount of Hepatitis C antibody testing undertaken from 2002/2003 to 2006 Majority of PCR testing performed at WSSVC in Glasgow Variety of testing and reporting algorithms applied at local laboratories following positive antibody result Median turn-around time for antibody and PCR test results at local and reference laboratories days